|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500107079 |
|
最近更新日期: Date of Last Refreshed on: |
2025-08-04 09:26:40 |
|
注册时间: Date of Registration: |
2025-08-04 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
基于最佳证据的出院准备服务方案在老年前列腺癌根治术患者中的应用研究 |
|
Public title: |
Effectiveness of Evidence-Based Discharge Preparation Services Program on elderly patients undergoing radical prostatectomy:A quasi-experimental study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
老年前列腺癌根治术后患者出院准备度循证干预方案的构建及验证 |
|
Scientific title: |
Construction and validation of evidence-based intervention pro-gram for discharge readiness of elderly patients after radical prostatectomy |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
顾云云 |
研究负责人: |
蔡英华 |
|
Applicant: |
Yunyun Gu |
Study leader: |
Cai Yinghua |
|
申请注册联系人电话: Applicant telephone: |
+86 158 5280 1236 |
研究负责人电话:
Study leader's |
+86 188 6180 6099 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
yunmonarch@163.com |
研究负责人电子邮件: Study leader's E-mail: |
179098331@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江苏省无锡市滨湖区中南西路8号 |
研究负责人通讯地址: |
江苏省无锡市梁溪区清扬路299号 |
|
Applicant address: |
No. 8, Zhongnan West Road, Binhu District, Wuxi City, Jiangsu Province, China |
Study leader's address: |
No.299 Qingyang Road, Liangxi District, Wuxi City, Jiangsu Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
南京中医药大学附属无锡医院 |
||
|
Applicant's institution: |
Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine |
||
|
研究负责人所在单位: |
南京医科大学附属无锡人民医院 |
||
|
Affiliation of the Leader: |
The Affiliated Wuxi People's Hospital of Nanjing Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
(2023) 科研伦审第(KY23063)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
无锡市人民医院科研伦理委员会 |
||
|
Name of the ethic committee: |
Research Ethics Committee of Wuxi People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-05-30 00:00:00 | ||
|
伦理委员会联系人: |
彭雁 |
||
|
Contact Name of the ethic committee: |
Yan Peng |
||
|
伦理委员会联系地址: |
江苏省无锡市梁溪区清扬路299号 |
||
|
Contact Address of the ethic committee: |
No.299 Qingyang Road, Liangxi District, Wuxi City, Jiangsu Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 510 8270 0778 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
南京医科大学附属无锡人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Affiliated Wuxi People's Hospital of Nanjing Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省无锡市梁溪区清扬路299号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.299 Qingyang Road, Liangxi District, Wuxi City, Jiangsu Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
本研究无经费资助。 |
||||||||||||||||||||||
|
Source(s) of funding: |
This research was not funded. |
||||||||||||||||||||||
|
研究疾病: |
前列腺癌 |
||||||||||||||||||||||
|
Target disease: |
prostate cancer |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
基于JBI循证卫生保健模式理论及出院准备概念模型,通过文献回顾形成老年前列腺癌根治术患者出院准备服务最佳证据总结,根据证据总结内容,从全程视角和整体性视角构建老年前列腺癌根治术后患者出院准备度干预方案,并验证干预方案的应用效果,以期提高老年前列腺癌根治术后患者的出院准备度、出院指导质量及生活质量。 |
||||||||||||||||||||||
|
Objectives of Study: |
Based on the theory of JBI evidence-based health care model and the conceptual model of discharge readiness, a summary of the best evidence on discharge readiness ser-vices for elderly patients undergoing radical prostatectomy was formed through a litera-ture review. Based on the content of the summary of the evidence, an intervention pro-gram on discharge readiness for elderly patients undergoing radical prostatectomy was constructed from the whole process perspective and holistic perspective, and the effec-tiveness of the program was verified, with the aim of improving the discharge readiness, quality of discharge instructions and quality of life of elderly patients after radical pros-tatectomy. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.年龄≥60岁; 2.经前列腺穿刺活检,病理确诊为前列腺癌后行前列腺癌根治术; 3.具备沟通能力; 4.知情同意且自愿参加本研究。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Age >= 60 years; 2. Patients who underwent radical prostatectomy after prostate biopsy and were pathologically diagnosed with prostate cancer; 3. Have communication skills; 4. Have given informed consent and are willing to participate in this study. |
||||||||||||||||||||||
|
排除标准: |
1.具有认知功能障碍、语言表达障碍、或视听觉障碍; 2.病情严重以致不能参加; 3.患者本人要求退出研究; 4.研究过程中因更换联系方式或死亡而无法联系。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Having cognitive dysfunction, language expression disorder, or visual and auditory impairment; 2. The condition is so severe that they cannot participate; 3. The patient requests to withdraw from the study; 4. Unable to be contacted during the study due to changes in contact information or death. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-07-01 00:00:00至 To 2023-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-07-01 00:00:00 至 To 2023-10-12 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男性 |
Gender: |
Male |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本研究为非随机对照研究。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
This study is a non-randomized controlled study. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究结束后6个月,经研究者同意后可邮箱获取 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Six months after the conclusion of the study, it can be obtained by email with the consent of the researcher. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
筛选符合标准的患者后,向患者介绍本研究的目的、意义,请患者签署“知情同意书”。在研究者的指导下,请患者根据实际情况填写调查表或者研究者以中性语气向患者阅读问题及可供选择的选项,患者作答,研究者帮其填写。所有的研究成员都将对患者的身份保密。档案将保存在泌尿外科病区档案柜中,仅供研究人员查阅。研究组成员在法律允许的范围内,尽一切努力保护患者的医疗资料的隐私。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
After screening the patients who meet the criteria, introduce the purpose and significance of this study to the patients, and ask them to sign the "Informed Consent Form". Under the guidance of the researchers, ask the patients to fill out the questionnaire according to the actual situation or let the researchers read the questions and the available options to the patients in a neutral tone, and have the patients answer. The researchers will help them fill it out. All the research members will keep the patients' identities confidential. The files will be stored in the archive cabinet of the urology ward and can only be accessed by the researchers. The members of the research group will do their best to protect the privacy of the patients' medical information within the legal limits. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |